Loading…
Underlying
Underlying Price
$38.90
Type
Put
Strike
40
Expiration
Nov 27, 2026
DTE
34d
Moneyness
ITM
Intrinsic
$1.10
NVO 40 Put Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Oct 23, 2026 | -1d | $0.62 | -36.73% | 41 | 487 |
| Oct 30, 2026 | 6d | $0.95 | -20.17% | 46 | 725 |
| Nov 6, 2026 | 13d | $1.59 | -20.50% | 18 | 1,984 |
| Nov 13, 2026 | 20d | $1.90 | -22.45% | 47 | 95 |
| Nov 20, 2026 | 27d | $1.98 | -7.91% | 368 | 12,012 |
| Nov 27, 2026 | 34d | $2.05 | -9.69% | 28 | 163 |
| Dec 18, 2026 | 55d | $2.37 | -4.82% | 102 | 13,297 |
| Jan 15, 2027 | 83d | $2.65 | -8.30% | 641 | 27,914 |
| Mar 19, 2027 | 146d | $3.57 | -4.03% | 18 | 4,810 |
| Jun 17, 2027 | 236d | $4.70 | -3.09% | 43 | 9,820 |
| Sep 17, 2027 | 328d | $5.35 | -3.60% | 1 | 4,074 |
| Dec 17, 2027 | 419d | $5.90 | -3.28% | 6 | 10,897 |
| Jan 21, 2028 | 454d | $6.04 | -4.13% | 39 | 7,730 |
| Jun 16, 2028 | 601d | $6.99 | -3.59% | 16 | 3,892 |
| Dec 15, 2028 | 783d | $7.97 | -5.46% | 2 | 1,591 |
| Jan 19, 2029 | 818d | $8.02 | -3.37% | 22 | 34 |
NVO Nearby Strikes · Nov 27, 2026
| Strike | Last | Change | Vol | Open Int | Moneyness |
|---|---|---|---|---|---|
| 34 P | $0.20 | +122.22% | 2 | 11,406 | OTM |
| 35 P | $0.37 | -7.50% | 5 | 52 | OTM |
| 36 P | $0.54 | -8.47% | 182 | 182 | OTM |
| 37 P | $0.79 | -15.96% | 29 | 131 | OTM |
| 38 P | $1.02 | -15.70% | 40 | 51 | OTM |
| 39 P | $1.52 | -12.14% | 218 | 242 | ITM |
| 40 P | $2.05 | -9.69% | 28 | 163 | ITM |
| 41 P | $3.00 | -10.45% | 1 | 14 | ITM |
| 42 P | $3.40 | -1.45% | 50 | 107 | ITM |
| 43 P | $4.73 | -10.75% | 2 | 9 | ITM |
| 44 P | $4.82 | -5.49% | 1 | 2 | ITM |
| 45 P | — | — | 0 | 0 | ITM |
| 46 P | — | — | 0 | 0 | ITM |
NVO Profile
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.